Introduction: In Ayurveda, Shukra Dhatu is considered essential for reproduction and vitality. Ksheena Shukra (Oligospermia) is characterized by decreased quantity and quality of semen, leading to infertility. Among Panchakarma therapies, Basti is regarded as “Ardha Chikitsa” due to its systemic action, especially in Vata disorders and Dhatu Kshaya conditions. Baladi Yapana Basti is indicated for Brimhana and Vrishya effects, while Ashwagandha Ghrita is widely known for its Shukra Vardhaka and Balya properties. Aim: To compare the efficacy of Baladi Yapana Basti and Ashwagandha Ghrita Snehapana in the management of Ksheena Shukra (Oligospermia). Materials and Methods: A randomized comparative clinical trial will be conducted at Ch. Brahm Prakash Ayurvedic Charak Sansthan from 2024 to 2026. A total of 52 patients will be randomly divided into two groups. Group A will receive Baladi Yapana Basti and Group B will receive Ashwagandha Ghrita Snehapana. Assessment will be done on semen parameters and clinical symptoms at baseline, after treatment, and follow-up. Results: The collected data will be statistically analyzed to evaluate and compare the efficacy of both interventions based on objective and subjective parameters. Discussion and Conclusion: The study will help to establish evidence-based comparative efficacy of Basti (Shodhana therapy) and Snehapana (Shamana therapy) in the management of Oligospermia.
*1Gaurav Kumar Meena, 2Pankaj Kumar Katara, 3Arun Gupta (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: